Technical Analysis for APLS - Apellis Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade C 24.21 4.81% 1.11
APLS closed up 4.81 percent on Tuesday, June 19, 2018, on approximately normal volume. It was able to find support at its 50 day moving average. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Up Up
See historical APLS trend table...

Date Alert Name Type % Chg
Jun 19 50 DMA Support Bullish 0.00%
Jun 19 MACD Bullish Centerline Cross Bullish 0.00%
Jun 19 Outside Day Range Expansion 0.00%
Jun 19 Above Upper BB Strength 0.00%
Jun 19 Overbought Stochastic Strength 0.00%
Jun 19 Up 3 Days in a Row Strength 0.00%
Jun 19 Up 4 Days in a Row Strength 0.00%
Jun 19 Up 5 Days in a Row Strength 0.00%
Jun 19 Upper Bollinger Band Touch Strength 0.00%
Jun 18 Crossed Above 50 DMA Bullish 4.81%

Older signals for APLS ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the discovery and development of therapeutic compounds for autoimmune and inflammatory diseases. The Company's lead compounds are designed to inhibit complement component 3 (C3), the central protein in the complement cascade. The Company is developing APL-2 for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) by subcutaneous injection, which is an injection into the tissue under the skin. It is developing APL-2 for the treatment of geographic atrophy (GA) and intermediate age-related macular degeneration (AMD) by intravitreal injection, which is an injection into the eye. The Company is developing APL-1 for the treatment of chronic obstructive pulmonary disease (COPD) by inhaled administration.
Is APLS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 0 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 32.0
52 Week Low 12.45
Average Volume 426,318
200-Day Moving Average 0.0
50-Day Moving Average 23.1201
20-Day Moving Average 20.9223
10-Day Moving Average 21.6235
Average True Range 1.5675
ADX 15.5
+DI 27.12
-DI 13.67
Chandelier Exit (Long, 3 ATRs ) 20.2175
Chandelier Exit (Short, 3 ATRs ) 23.5925
Upper Bollinger Band 23.3282
Lower Bollinger Band 18.5164
Percent B (%b) 1.18
BandWidth 22.998428
MACD Line 0.0428
MACD Signal Line -0.4518
MACD Histogram 0.4946
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 27.17
Resistance 3 (R3) 26.86 25.58 26.67
Resistance 2 (R2) 25.58 24.82 25.73 26.51
Resistance 1 (R1) 24.89 24.36 25.24 25.20 26.34
Pivot Point 23.61 23.61 23.78 23.76 23.61
Support 1 (S1) 22.92 22.85 23.27 23.23 22.08
Support 2 (S2) 21.64 22.39 21.79 21.91
Support 3 (S3) 20.95 21.64 21.75
Support 4 (S4) 21.26